Orthopedic Implants Global Market Report 2025

The orthopedic implants market size has grown strongly in recent years. It will grow from $38.87 billion in 2024 to $41.22 billion in 2025 at a compound annual growth rate (CAGR) of 6.1%. The growth during the historical period can be attributed to factors such as the increasing aging population, a rise in bone-related disorders, greater demand for minimally invasive procedures, higher healthcare spending, and broader global access to orthopedic care.

The orthopedic implants market size is expected to see strong growth in the next few years. It will grow to $51.67 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth anticipated during the forecast period is driven by factors such as the rising demand for personalized and 3D-printed implants, a growing focus on minimally invasive surgery, the expansion of outpatient orthopedic procedures, an aging population, and improved reimbursement models that support value-based care. Key trends in the forecast period include the use of bioresorbable materials, the implementation of 3D printing for custom implants, the integration of smart implants with sensor technology, advances in minimally invasive surgical techniques, better surface coatings, and the incorporation of AI in surgical planning.

The rising demand for bone implantations is expected to drive the growth of the orthopedic implants market in the coming years. Bone implantations involve the surgical placement of artificial materials, such as metal or ceramic implants, into bones to repair, replace, or support damaged or missing bone structures. The increase in bone implantations is largely due to the growing prevalence of osteoporosis and fractures among aging populations, which require surgical procedures such as bone grafting to restore functionality and mobility. Orthopedic implants play a crucial role in these procedures by replacing, supporting, or stabilizing damaged bones, helping to restore function and promote healing. For example, in August 2024, Healthy Bones Australia, a non-profit organization, reported that 6.2 million Australians aged 50 and older had poor bone health in 2023, with 77% affected by osteopenia and 23% by osteoporosis. This number is expected to grow to 7.7 million by 2033, further fueling the demand for bone implantations and driving the growth of the orthopedic implants market.

Leading companies in the orthopedic implants sector are concentrating on innovations such as advanced orthopedic fixation systems to improve implant stability, enhance pullout strength in cancellous bone, and ensure long-term fixation in orthopedic surgeries. Orthopedic fixation systems are medical devices that stabilize and support broken or surgically altered bones, aiding in proper alignment and healing through internal or external mechanical support. For example, in March 2025, Orthopedic Implant Company, a US-based surgical implant manufacturer, introduced the mini fragment plating system, which provides customizable and efficient solutions for orthopedic trauma surgeries. With its flexible plate designs, advanced screw options, and surgeon-friendly features, the system simplifies inventory management, supports value-based care, and maintains high clinical performance.

In February 2024, Zeda Inc., a US-based technology solutions company, acquired Orthopedic Implant Company for an undisclosed sum. This acquisition allows Zeda to expand its presence in the orthopedic market, accelerate innovation in value-based implant manufacturing, and make high-quality, affordable orthopedic care more accessible to patients worldwide. Orthopedic Implant Company, a US-based manufacturer of surgical implants, specializes in producing orthopedic implants.

Major players in the orthopedic implants market are Johnson & Johnson, Stryker Corporation, Zimmer Biomet, Smith And Nephew plc, Arthrex Inc., Enovis Corporation, Integra LifeSciences Holdings Corporation, NuVasive Inc., ConMed Corporation, Medacta International, Orthofix Medical Inc., Exactech Inc., B. Braun Melsungen AG, Acumed, Xtant Medical Holdings, Think Surgical, Narang Medical Limited, Siora Surgical Pvt. Ltd., Auxein Medical, Adler Ortho.

North America was the largest region in the orthopedic implants market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in orthopedic implants report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the orthopedic implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Orthopedic implants are medical devices surgically inserted to support or replace damaged or deteriorated bones, joints, or cartilage. They are used to enhance mobility, alleviate pain, and help the body restore function following trauma or due to bone-related conditions.

The primary categories of orthopedic implants include knee implants, dental implants, hip implants, spinal implants, and more. Knee implants are synthetic devices created to replace worn or damaged knee joints caused by arthritis or injury. These implants are crafted from a variety of biomaterials, including ceramic, metal, polymer-based substances, and others. Orthopedic implants are commonly utilized in various healthcare environments, including hospitals, orthopedic clinics, ambulatory surgical centers, and similar facilities.

The orthopedic implants market research report is one of a series of new reports that provides orthopedic implants market statistics, including the orthopedic implants industry global market size, regional shares, competitors with the orthopedic implants market share, detailed orthopedic implants market segments, market trends, and opportunities, and any further data you may need to thrive in the orthopedic implants industry. This orthopedic implant market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The orthopedic implants market consists of sales of plates, screws, rods, and joint replacements used to treat musculoskeletal issues, including bone fractures, deformities, and joint degeneration. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.